LOS ANGELES, May 1, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Landstar System, Inc. ("Landstar" or "the Company") (NASDAQ: LSTR) for violations of the securities laws.The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Landstar admitted on April 2, 2025, that it had "identified a significant sup ...

SAN DIEGO, April 30, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP reminds investors it has filed a class action lawsuit on behalf of all purchasers of Fluence Energy, Inc. ("Fluence") (NASDAQ: FLNC) Class A stock between October 28, 2021 and February 10, 2025 (the "Class Period"). The complaint alleges violations of sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and U.S. Securities and Exchange Commission Rule 10b-5, promulgated thereunder. The complaint seeks relief on ...

Core Viewpoint - A class action lawsuit has been filed against Napco Security Technologies, Inc. for allegedly misleading investors about its growth projections and sales performance during the specified period [1][2]. Group 1: Allegations and Financial Performance - Robbins LLP is investigating claims that Napco Security Technologies misled investors regarding its ability to meet fiscal 2026 growth projections, failing to disclose the true state of demand forecasting and distributor negotiations [2]. - The complaint highlights that Napco made optimistic long-term projections while downplaying setbacks in hardware sales, which ultimately led to a decline in sales and failure to meet projections [2]. - On February 3, 2025, Napco announced disappointing financial results for Q2 of fiscal 2025, revealing a significant reduction in hardware sales, causing its stock price to drop approximately 26.62% from $36.70 on January 31, 2024, to $26.93 on February 3, 2025 [3]. Group 2: Class Action Participation - Shareholders interested in serving as lead plaintiffs in the class action must file their papers by June 24, 2025, with the lead plaintiff representing other class members in the litigation [4]. - Shareholders are not required to participate in the case to be eligible for recovery and can remain absent class members if they choose not to take action [4]. Group 3: Legal Representation - Robbins LLP operates on a contingency fee basis, meaning shareholders incur no fees or expenses unless the case is won [5]. - The firm has been dedicated to helping shareholders recover losses and improve corporate governance since 2002 [5].

Core Viewpoint - A class action has been filed against Rocket Lab USA, Inc. for allegedly misleading investors regarding its business prospects during a specific period [1][2]. Allegations - The complaint alleges that Rocket Lab failed to disclose significant delays in its plans for three barge landing tests [2]. - A critical potable water issue was not scheduled to be resolved until January 2026, which impacted the launch pad preparation [2]. - Due to these issues, there was a substantial risk that Rocket Lab's Neutron rocket would not launch as planned in mid-2025 [2]. - The only contract for the Neutron rocket was made at a discount with an unreliable partner [2]. - As a result of these factors, the positive statements made by the defendants about the company's business and prospects were materially misleading [2]. Stock Price Impact - Following the revelation of these issues on February 25, 2025, Rocket Lab's stock price dropped by $2.21, or 9.8%, closing at $20.28 per share [3]. Class Action Participation - Shareholders interested in serving as lead plaintiffs must file their papers with the court by April 28, 2025 [4]. - Participation in the case is not required to be eligible for recovery, allowing shareholders to remain absent class members if they choose [4]. Company Background - Robbins LLP is recognized for its leadership in shareholder rights litigation, focusing on helping shareholders recover losses and improve corporate governance since 2002 [5].

Group 1 - A class action has been filed against NET Power Inc. on behalf of investors who purchased securities between June 9, 2023, and March 7, 2025 [1] - The allegations include that NET Power misled investors about the timeline and costs associated with Project Permian, indicating that the project would be delayed and more expensive than previously stated due to supply chain issues and other challenges [2] - Following the announcement of third quarter 2023 results, NET Power's stock fell over 18% after revealing a 12-month delay in the expected schedule for Project Permian [3] Group 2 - On March 10, 2025, NET Power disclosed that the total installed cost for Project Permian is now estimated to be between $1.7 billion and $2.0 billion, significantly higher than the previous estimate of $1.1 billion, and announced a delay in the project's timeline to no earlier than 2029 [4] - The company reported a decrease in cash and cash equivalents from $580 million to $533 million, primarily due to operating cash outflows and capital expenditures [4] - Following the fourth quarter and full year 2024 results announcement, NET Power's stock price fell over 31% to close at $4.75 per share [4]

SAN DIEGO, April 21, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons who purchased or otherwise acquired Zenas BioPharma, Inc. (NASDAQ: ZBIO) securities pursuant and/or traceable to the registration statement and related prospectus issued in connection with Zenas BioPharma's September 2024 initial public offering. Zenas BioPharma purports to be a “clinical stage global biopharmaceutical company committed to being a leader in the development a ...

Core Viewpoint - A class action lawsuit has been filed against Bakkt Holdings, Inc. for allegedly misleading investors about the stability and diversity of its crypto services revenue, particularly its reliance on a single contract with Webull [1][2]. Group 1: Allegations and Financial Impact - The complaint alleges that Bakkt misrepresented the stability and diversity of its crypto services revenue and failed to disclose its substantial dependence on a single contract with Webull [2]. - Bakkt disclosed that Webull accounted for 74% of its crypto services revenue for the nine months ending September 30, 2024, and that 98% of its total revenue came from crypto services during the same period [3]. - Following the announcement of Webull's termination of their commercial agreement, Bakkt is expected to face a 73% loss in top-line revenue, leading to a significant drop in share price by $3.50 or 27.3% to close at $9.33 per share on March 18, 2025 [3]. Group 2: Legal Proceedings and Participation - Shareholders are encouraged to participate in the class action against Bakkt Holdings, with options to serve as lead plaintiff or remain an absent class member [4]. - Robbins LLP operates on a contingency fee basis, meaning shareholders will incur no fees or expenses for representation [5].

Core Viewpoint - Class actions have been initiated on behalf of stockholders of Solaris Energy Infrastructure, Actinium Pharmaceuticals, Bakkt Holdings, and Cerevel Therapeutics, with specific allegations of misleading statements and omissions of material facts regarding their business operations and prospects [1]. Solaris Energy Infrastructure, Inc. (NYSE: SEI) - Class period is from July 9, 2024, to March 17, 2025, with a lead plaintiff deadline of May 27, 2025 [2]. - Allegations include failure to disclose that Mobile Energy Rentals LLC had minimal corporate history, lacked a diversified earnings stream, and was co-owned by a convicted felon associated with turbine-related fraud [2]. - Claims that Solaris overstated commercial prospects from an acquisition and inflated profitability metrics by not properly depreciating turbines, leading to materially misleading statements [2]. Actinium Pharmaceuticals, Inc. (NYSE: ATNM) - Class period is from October 31, 2022, to August 2, 2024, with a lead plaintiff deadline of May 26, 2025 [3]. - The complaint alleges that Actinium made false claims regarding the strength of data submitted to the FDA for its Biologics License Application for Iomab-B, later admitting the need for additional clinical trials [3]. - Public statements were deemed materially misleading, resulting in investor damages when the truth was revealed [3]. Bakkt Holdings, Inc. (NYSE: BKKT) - Class period is from March 25, 2024, to March 17, 2025, with a lead plaintiff deadline of June 2, 2025 [4]. - Allegations include misrepresentation of the stability and diversity of crypto services revenue, which was heavily reliant on a single contract with Webull [4]. - Positive statements about the company's business were claimed to be materially misleading due to undisclosed dependencies [4]. Cerevel Therapeutics Holdings, Inc. (CERE) - Class period is from October 11, 2023, to August 1, 2024, with a lead plaintiff deadline of June 3, 2025 [6]. - The complaint alleges that Cerevel's offering documents omitted material facts about AbbVie's interest in acquiring the company at a significantly higher price than the offering price of $22.81 per share [6]. - Claims that Cerevel's controlling shareholder acquired shares at an artificially depressed price while possessing nonpublic information, leading to a substantial windfall when AbbVie announced the acquisition at $45 per share [6][7].

Core Viewpoint - Robbins LLP has initiated a class action lawsuit on behalf of investors who acquired ModivCare, Inc. (NASDAQ: MODV) securities between November 3, 2022, and September 15, 2024, alleging that the company misled investors regarding its business prospects [1][2]. Allegations - The complaint states that ModivCare failed to disclose that certain contracts in its Non-Emergency Medical Transportation (NEMT) segment led to a deterioration in the company's free cash flow [2]. - As a result of these undisclosed issues, the company experienced negative impacts on adjusted EBITDA due to contract renegotiations and pricing accommodations, and it faced liquidity challenges [2][3]. - The positive statements made by the company regarding its business operations and prospects were deemed materially misleading and lacked a reasonable basis [2][3]. Legal Proceedings - Shareholders interested in serving as lead plaintiffs in the class action must file necessary documents with the court by March 31, 2025 [4]. - Participation in the case is not required to be eligible for recovery, allowing shareholders to remain absent class members if they choose [4]. Company Background - Robbins LLP is recognized for its leadership in shareholder rights litigation, focusing on helping shareholders recover losses and improve corporate governance since 2002 [5].